2har: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The crystal structure of the vitamin D receptor (VDR) in complex with 1, alpha,25(OH)2D3 revealed the presence of several water molecules near the, A-ring linking the ligand C-2 position to the protein surface. Here, we, report the crystal structures of the human VDR ligand binding domain bound, to selected C-2 alpha substituted analogues, namely, methyl, propyl, propoxy, hydroxypropyl, and hydroxypropoxy. These specific replacements do, not modify the structure of the protein or the ligand, but with the, exception of the methyl substituent, all analogues affect the presence, and/or the location of the above water molecules. The integrity of the, channel interactions and specific C-2 alpha analogue directed additional, interactions correlate with the binding affinity of the ligands. In, contrast, the resulting loss or gain of H-bonds does not reflect the, magnitude of HL60 cell differentiation. Our overall findings highlight a, rational approach to the design of more potent ligands by building in, features revealed in the crystal structures.
The crystal structure of the vitamin D receptor (VDR) in complex with 1 alpha,25(OH)2D3 revealed the presence of several water molecules near the A-ring linking the ligand C-2 position to the protein surface. Here, we report the crystal structures of the human VDR ligand binding domain bound to selected C-2 alpha substituted analogues, namely, methyl, propyl, propoxy, hydroxypropyl, and hydroxypropoxy. These specific replacements do not modify the structure of the protein or the ligand, but with the exception of the methyl substituent, all analogues affect the presence and/or the location of the above water molecules. The integrity of the channel interactions and specific C-2 alpha analogue directed additional interactions correlate with the binding affinity of the ligands. In contrast, the resulting loss or gain of H-bonds does not reflect the magnitude of HL60 cell differentiation. Our overall findings highlight a rational approach to the design of more potent ligands by building in features revealed in the crystal structures.


==Disease==
==Disease==
Line 22: Line 22:
[[Category: alpha helical sandwich]]
[[Category: alpha helical sandwich]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:30:55 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:39:54 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA